Discussion on the pharmaceutical development of digital medicine and long-acting injections of aripiprazole
10.13699/j.cnki.1001-6821.2024.10.030
- VernacularTitle:阿立哌唑智能制剂和长效注射剂的药学研究探究
- Author:
Xiao-Fei SI
1
;
Qian TANG
;
Chen-Chen XI
;
Dian-Zhuo JIANG
Author Information
1. 国家药品监督管理局药品审评中心,北京 100076
- Keywords:
aripiprazole;
digital medicine;
long-acting injection;
China encourage generic drug catalogue;
formulation and manufacturing process development;
quality control;
pharmaceutical research
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(10):1535-1540
- CountryChina
- Language:Chinese
-
Abstract:
Aripiprazole drug products have been used widely for treatment of schizophrenia.The digital medicine and long-acting injections of aripiprazole have received widespread attention in recent years,which can improve patient compliance to some extent.Based on literature investigation,combined with analysis long-acting injections of aripiprazole in China'Encourage generic drug catalogue(third batch)',the approval cases were summarized,and the pharmaceutical considerations were put forward in terms formulation,manufacturing process and quality control,aimed to provide scientific reference for research and development of such drugs.
